The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Humana refiles Medicare Advantage star ratings suit Humana is taking a second bite at the apple to improve its sunken MA stars, filing an edited complaint with a Texas court on Monday. The insurer ...

Humana losing star ratings is a big set-back that lead to its share price falling by 7.5% before paring losses.

Humana lost its legal challenge to restore the quality ratings of its Medicare plans in a significant blow to future earnings potential. A Texas district court ruled Friday against Humana, saying ...

Humana Inc. shares fell after it lost a lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped the court would restore billions in revenue.

Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.

By Nicholas G. Miller Humana lost its legal challenge to restore the quality ratings of its Medicare plans in a significant blow to future earnings potential.

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare Advantage plans.

The company’s growing portfolio includes well-established brands such as Cologuard ® and Oncotype DX ®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence ...